Oslo University Hospital
Oslo, 0372, Norway
NCT Number: NCT06860139
The goal of this complex interventions study is to improve health literacy (HL), medication adherence and patient education outcomes in immigrant kidney transplant recipients (KTRs). Furthermore, we aim to strengthen HL sensitivity and cultural competence in nurses providing patient education. The main questions we aims to answer are:
1. What are immigrant KTRs HL strengths and needs, medication adherence and outcomes after patient education in three important transitions following kidney transplantation: the first postoperative phase (3-7 days post-transplantation), preparing for transfer to local hospital (6-8 weeks post-transplantation), and adapting to the home context (3-6 months post-transplantation). 2. What experiences, competence and competence needs does the nurses that engage in patient education to immigrant KTRs post-transplant have? 3. Will a tailored intervention increase HL, medication adherence, and outcomes after patient education in immigrant KTXs and organizational HL and cultural competence in nurses?
Qualitative methods will be used to develop and optimize the intervention.
* Patients will be invited to three individual interviews in the three postoperative phases. * Nurses in three wards (surgery, medical and outpatient ward) are asked to participants in focus group interviews. * The interviews will be used to define needs and build the intervention. Ideas to the intervention will be discussed in workshops with nurses, the project group and user participants. * Parts of the intervention will be tested in the clinic followed by 'think aloud interviews' where both the nurse and the patient are asked to speak freely about their experiences using the intervention. * The intervention will be evaluated by repeating the interviews with patient and focus group interviews with nurses. * The intervention will be feasibility tested.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Oslo, 0372, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention will be developed in co-creation with patients and nurses in the clinic, based on their needs.
Time frame: November 2027
Patients experiences from patient education, health literacy (strengths, challenges, expectations and needs), information about medication adherence and transplant knowledge will be collected using qualitative interviews. The interview guide is developed using the conversational health literacy tool (CHAT), that involve questions about health literacy. The tool is flexible and adaptable to the transplant context and will also involve questions regarding medication adherence and transplant knowledge.
Nurses experience from giving patient education will be collected through focus group interviews. The interview guide involves the following four main themes: experiences giving patient education to immigrant kidney transplant recipient, giving patient education using an interpreter, competence and competence needs and documenting patient education with immigrant patients.
Quantitative measures are not used.
Oslo University Hospital
Other
Acronym: IMMIHEALTH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06972069
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial DetailsNCT06701825
Chronic Disease, Disease Attributes
Madrid, Spain
View Trial DetailsNCT06759831
Transplant Recipient (Kidney)
Bologna, BO, Italy
View Trial DetailsNCT01277770
Post-Transplant Infections, Steroid-Free Maintenance Immunosuppression
Minneapolis, Minnesota, United States
View Trial Details